治疗急性心力衰竭的利尿剂组合:随机临床试验的系统审查与网络元分析和试验顺序分析的方案
Nihal Nahiz1, Jasmin Dam Lukoschewitz2, Ekim Seven3
1Department of Cardiology, Hvidovre Hospital, Copenhagen University Hospital, Hvidovre, Denmark wdb580@alumni.ku.dk.
BMJ open
|April 8, 2024
概括
本系统性审查将检查急性心力衰竭 (AHF) 的利尿疗法,以找到患有液体过载的患者的最佳干预措施. 目标是改善治疗结果,减少这种危急病的死亡率.
科学领域:
- 心脏病学 心脏病学
- 药理学 药理学是指药理学的学科.
- 临床研究 临床研究
背景情况:
- 急性心力衰竭 (AHF) 是一种严重的疾病,死亡率高,影响全球数百万人.
- 目前的AHF治疗,通常涉及静脉注射利尿剂用于液体过载,缺乏最佳药物组合的强有力的证据.
- 肺堵塞和流体过载是常见的症状,需要有效的管理.
研究的目的:
- 系统地审查对急性心力衰竭与体积过载的利尿干预的随机对照试验.
- 在住院的AHF患者中研究各种利尿治疗的疗效和安全性.
- 确定最佳的利尿剂策略,以改善患者的治疗结果.
主要方法:
- 随机对照试验 (RCT) 的系统审查.
- 在主要的数据库中进行搜索:Embase,Medline,LILACS,科学网,Cochrane.
- 主要结局:全因死亡率;次要结局:不良事件,再入院,功能衰竭.
主要成果:
- 该部分将在研究完成后填写.
- 该审查将分析包含在其中的RCT中报告的最长的随访数据.
- 在适当的情况下,将采用潜在的元分析,试验顺序分析和网络元分析.
结论:
- 这一系统性审查将提供基于证据的见解,以治疗急性心力衰竭的利尿剂治疗.
- 这些发现旨在指导临床实践,并改善体积过载的AHF患者的治疗策略.
- 这项研究将有助于减少与AHF相关的死亡率和发病率.
更多相关视频
09:20Lumped-Parameter and Finite Element Modeling of Heart Failure with Preserved Ejection Fraction
Published on: February 13, 2021
6.4K
10:38Observational Study Protocol for Repeated Clinical Examination and Critical Care Ultrasonography Within the Simple Intensive Care Studies
Published on: January 16, 2019
20.2K
相关概念视频
01:22Heart Failure Drugs: Diuretics
370
Heart failure and kidney perfusion are interconnected in a complex way. Reduced renal perfusion and venous congestion are two significant factors that contribute to renal dysfunction in heart failure. The kidneys, primarily responsible for fluid balance in the body, are adversely affected due to compromised cardiac output and increased venous pressure. In response to reduced renal perfusion, the kidneys activate neurohumoral mechanisms to restore balance. However, these mechanisms can be...
370
01:26Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
422
The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
422
01:26Heart Failure Drugs: Inotropic Agents
577
Positive inotropic agents are commonly used as the first line of treatment for heart failure. One such agent is digoxin, derived from the genus Digitalis, which has been known for centuries but effectively utilized since 1785. However, these cardiac glycosides can have potentially toxic effects due to their mechanism of action, which involves inhibiting Na+/K+-ATPase and increasing contractility. Digoxin is absorbed orally and distributed in various tissues, including the CNS. It has a long...
577
01:22Heart Failure Drugs: β-Blockers
337
β-adrenergic antagonists, commonly known as β-blockers, block the effects of sympathetic neurotransmitters such as noradrenaline (NA) and adrenaline (ADR). They have several beneficial effects in heart failure treatment. They reduce heart rate, the force of contraction, and cardiac muscle relaxation. They also slow the atrial-ventricular conduction rate and raise the threshold for arrhythmias. The concentration of β-blockers determines their effects on bronchodilation,...
337
01:16Antihypertensive Drugs: Action of Diuretics
679
Diuretics are antihypertensive drugs used to treat hypertension resulting from sodium and water retention. Sodium, vital for fluid balance and nerve or muscle function, is regulated by the kidneys through millions of nephrons. Blood enters nephrons via afferent arterioles, which branch into capillaries called glomeruli. These filter blood plasma, allowing water and solutes, like sodium ions, to pass through capillary walls into Bowman's capsule. The filtrate then flows through various...
679
01:28Antihypertensive Drugs: Potassium-Sparing Diuretics
531
Liddle syndrome is a genetically inherited form of hypertension characterized by the overactivity of epithelial sodium channels in the nephron, the functional unit of the kidney. This heightened activity leads to increased sodium reabsorption and excessive excretion of potassium. To counteract this, potassium-sparing diuretics such as amiloride are used. They function by blocking these sodium channels, thereby reducing the influx of sodium into the epithelial cells and minimizing the loss of...
531